{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:53:58Z","timestamp":1790682838839,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["International Orthopaedics (SICOT)"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Neuropathic pain is a complex and challenging condition that arises from abnormal processing of somatosensory information, often following nerve injury or dysfunction. Its diagnosis involves a detailed clinical history, sensory examination, and diagnostic tests such as electromyography, nerve conduction studies, and MRI to identify nerve damage or structural causes. In athletes, neuropathic pain can result from nerve entrapment syndromes, post-surgical complications, or peripheral nerve injuries, with unique challenges in pain assessment due to psychological factors and exercise-induced changes. Pharmacological management primarily includes anticonvulsants (e.g., gabapentin, pregabalin) and antidepressants (e.g., tricyclics, SNRIs), tailored to minimize side effects that could impair athletic performance. Effective treatment requires a careful balance to manage pain while maintaining physical capabilities. When treating athletes for neuropathic pain, healthcare providers must ensure prescribed medications comply with World Anti-Doping Agency (WADA) regulations. Narcotics (opioids) and cannabinoids are prohibited in-competition. Glucocorticoids are also banned in-competition if administered via injection, orally, or rectally, and elevated levels in urine may lead to sanctions.<\/jats:p>","DOI":"10.1007\/s00264-025-06440-4","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T05:04:54Z","timestamp":1739336694000},"page":"951-958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmaceutical considerations in treating neuropathic pain in athletes"],"prefix":"10.1007","volume":"49","author":[{"given":"Sina","family":"Ramtin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"6440_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/J.PMN.2016.05.008","volume":"17","author":"L Bettini","year":"2016","unstructured":"Bettini L, Moore K (2016) Central Sensitization in Functional Chronic Pain syndromes: overview and clinical application. Pain Manag Nurs 17:333\u2013338. https:\/\/doi.org\/10.1016\/J.PMN.2016.05.008","journal-title":"Pain Manag Nurs"},{"key":"6440_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/J.PAIN.0000000000000753","volume":"158","author":"R Baron","year":"2017","unstructured":"Baron R, Maier C, Attal N et al (2017) Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles. Pain 158:261\u2013272. https:\/\/doi.org\/10.1097\/J.PAIN.0000000000000753","journal-title":"Pain"},{"key":"6440_CR3","unstructured":"Neuropathic Pain (NeuPSIG) - International Association for the Study of Pain (IASP) (2025) https:\/\/www.iasp-pain.org\/membership\/special-interest-groups-sigs\/neuropathic-pain-neupsig\/. Accessed 5 Jan"},{"key":"6440_CR4","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1097\/J.PAIN.0000000000000492","volume":"157","author":"NB Finnerup","year":"2016","unstructured":"Finnerup NB, Haroutounian S, Kamerman P et al (2016) Neuropathic pain: an updated grading system for research and clinical practice. Pain 157:1599. https:\/\/doi.org\/10.1097\/J.PAIN.0000000000000492","journal-title":"Pain"},{"key":"6440_CR5","doi-asserted-by":"publisher","first-page":"e001828","DOI":"10.1136\/BMJSEM-2023-001828","volume":"10","author":"K Todd","year":"2024","unstructured":"Todd K, Kramer J, Olsen K, Martin Ginis K (2024) I don\u2019t know the correct way to describe it: neuropathic pain experiences among athletes with spinal cord injury. BMJ Open Sport Exerc Med 10:e001828. https:\/\/doi.org\/10.1136\/BMJSEM-2023-001828","journal-title":"BMJ Open Sport Exerc Med"},{"key":"6440_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.5114\/BIOLSPORT.2022.110744","volume":"39","author":"Y AlMakadma","year":"2021","unstructured":"AlMakadma Y, Eirale C, Chamari K (2021) Neuropathic pain in athletes: basics of diagnosis and monitoring of a hidden threat. Biol Sport 39:943. https:\/\/doi.org\/10.5114\/BIOLSPORT.2022.110744","journal-title":"Biol Sport"},{"key":"6440_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3344\/KJP.2018.31.1.54","volume":"31","author":"V Wegener","year":"2018","unstructured":"Wegener V, St\u00e4bler A, Jansson V et al (2018) Lumbar burner and stinger syndrome in an elderly athlete. Korean J Pain 31:54. https:\/\/doi.org\/10.3344\/KJP.2018.31.1.54","journal-title":"Korean J Pain"},{"key":"6440_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/J.AMJMED.2009.04.007","author":"AB O\u2019Connor","year":"2009","unstructured":"O\u2019Connor AB, Dworkin RH (2009) Treatment of neuropathic pain: an overview of recent guidelines. Am J Med. https:\/\/doi.org\/10.1016\/J.AMJMED.2009.04.007. 122:","journal-title":"Am J Med"},{"key":"6440_CR9","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1517\/14656561003767449","volume":"11","author":"JM Zakrzewska","year":"2010","unstructured":"Zakrzewska JM (2010) Medical management of trigeminal neuropathic pains. Expert Opin Pharmacother 11:1239\u20131254. https:\/\/doi.org\/10.1517\/14656561003767449","journal-title":"Expert Opin Pharmacother"},{"key":"6440_CR10","doi-asserted-by":"publisher","first-page":"1039529","DOI":"10.3389\/FNEUR.2022.1039529","volume":"13","author":"H Yang","year":"2023","unstructured":"Yang H, Dong Y, Wang Z et al (2023) Traumatic neuromas of peripheral nerves: diagnosis, management and future perspectives. Front Neurol 13:1039529. https:\/\/doi.org\/10.3389\/FNEUR.2022.1039529","journal-title":"Front Neurol"},{"key":"6440_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/J.PAIN.2007.08.033","volume":"132","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, O\u2019Connor AB, Backonja M et al (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132:237\u2013251. https:\/\/doi.org\/10.1016\/J.PAIN.2007.08.033","journal-title":"Pain"},{"key":"6440_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/BMJ.B3002","volume":"339","author":"R Freynhagen","year":"2009","unstructured":"Freynhagen R, Bennett MI (2009) Diagnosis and management of neuropathic pain. BMJ 339:391\u2013395. https:\/\/doi.org\/10.1136\/BMJ.B3002","journal-title":"BMJ"},{"key":"6440_CR13","doi-asserted-by":"publisher","unstructured":"Secrist ES, Freedman KB, Ciccotti MG et al (2015) Pain Management after Outpatient Anterior Cruciate Ligament Reconstruction. 44(2435\u20132447). https:\/\/doi.org\/10.1177\/0363546515617737. https:\/\/doi.org\/10.1177\/0363546515617737","DOI":"10.1177\/0363546515617737"},{"key":"6440_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0304-3959(96)03140-5","volume":"68","author":"HJ McQuay","year":"1996","unstructured":"McQuay HJ, Tram\u00e8r M, Nye BA et al (1996) A systematic review of antidepressants in neuropathic pain. Pain 68:217\u2013227. https:\/\/doi.org\/10.1016\/S0304-3959(96)03140-5","journal-title":"Pain"},{"key":"6440_CR15","doi-asserted-by":"publisher","unstructured":"Derry S, Wiffen PJ, Aldington D, Moore RA (2015) Nortriptyline for neuropathic pain in adults. Cochrane Database Syst Rev 2015:CD011209. https:\/\/doi.org\/10.1002\/14651858.CD011209.PUB2","DOI":"10.1002\/14651858.CD011209.PUB2"},{"key":"6440_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/J.PAIN.2005.08.013","volume":"118","author":"NB Finnerup","year":"2005","unstructured":"Finnerup NB, Otto M, McQuay HJ et al (2005) Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118:289\u2013305. https:\/\/doi.org\/10.1016\/J.PAIN.2005.08.013","journal-title":"Pain"},{"key":"6440_CR17","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/JAMA.2013.2813","volume":"309","author":"EML Smith","year":"2013","unstructured":"Smith EML, Pang H, Cirrincione C et al (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309:1359\u20131367. https:\/\/doi.org\/10.1001\/JAMA.2013.2813","journal-title":"JAMA"},{"key":"6440_CR18","doi-asserted-by":"publisher","unstructured":"Gallagher HC, Gallagher RM, Butler M et al (2015) Venlafaxine for neuropathic pain in adults. Cochrane Database Syst Rev 2015:CD011091. https:\/\/doi.org\/10.1002\/14651858.CD011091.PUB2","DOI":"10.1002\/14651858.CD011091.PUB2"},{"key":"6440_CR19","doi-asserted-by":"publisher","first-page":"e15169","DOI":"10.7759\/CUREUS.15169","volume":"13","author":"T Hirase","year":"2021","unstructured":"Hirase T, Hirase J, Ling J et al (2021) Duloxetine for the treatment of chronic low back Pain: a systematic review of Randomized Placebo-Controlled. Trials Cureus 13:e15169. https:\/\/doi.org\/10.7759\/CUREUS.15169","journal-title":"Trials Cureus"},{"key":"6440_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/TCRM.S17428","volume":"8","author":"HS Smith","year":"2012","unstructured":"Smith HS, Smith EJ, Smith BR (2012) Duloxetine in the management of chronic musculoskeletal pain. Ther Clin Risk Manag 8:267. https:\/\/doi.org\/10.2147\/TCRM.S17428","journal-title":"Ther Clin Risk Manag"},{"key":"6440_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/CPAA.S9795","volume":"2","author":"G Hans","year":"2010","unstructured":"Hans G, Robert D, Verhulst J, Vercauteren M (2010) Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician. Clin Pharmacol 2:65. https:\/\/doi.org\/10.2147\/CPAA.S9795","journal-title":"Clin Pharmacol"},{"key":"6440_CR22","doi-asserted-by":"publisher","unstructured":"Gammaitoni AR, Galer BS, Onawola R et al (2004) Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Curr Med Res Opin 20. https:\/\/doi.org\/10.1185\/030079904X12951","DOI":"10.1185\/030079904X12951"},{"key":"6440_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1756285613501576","volume":"7","author":"JF Peppin","year":"2014","unstructured":"Peppin JF, Pappagallo M (2014) Capsaicinoids in the treatment of neuropathic pain: a review. Ther Adv Neurol Disord 7:22. https:\/\/doi.org\/10.1177\/1756285613501576","journal-title":"Ther Adv Neurol Disord"},{"key":"6440_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/J.REUMA.2016.07.008","volume":"14","author":"V Guedes","year":"2018","unstructured":"Guedes V, Castro JP, Brito I (2018) Topical capsaicin for pain in osteoarthritis: a literature review. Reumatol Clin 14:40\u201345. https:\/\/doi.org\/10.1016\/J.REUMA.2016.07.008","journal-title":"Reumatol Clin"},{"key":"6440_CR25","doi-asserted-by":"publisher","unstructured":"Perez RS, Zollinger PE, Dijkstra PU et al (2010) Evidence based guidelines for complex regional pain syndrome type 1. BMC Neurology 2010 10:1 10:1\u201314. https:\/\/doi.org\/10.1186\/1471-2377-10-20","DOI":"10.1186\/1471-2377-10-20"},{"key":"6440_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/J.JCHEMNEU.2017.08.006","volume":"87","author":"AA Kaplan","year":"2018","unstructured":"Kaplan AA, Yurt KK, Deniz \u00d6G, Altun G (2018) Peripheral nerve and diclofenac sodium: Molecular and clinical approaches. J Chem Neuroanat 87:2\u201311. https:\/\/doi.org\/10.1016\/J.JCHEMNEU.2017.08.006","journal-title":"J Chem Neuroanat"},{"key":"6440_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/ALN.0000000000000693","volume":"123","author":"SU Ahmed","year":"2015","unstructured":"Ahmed SU, Zhang Y, Chen L et al (2015) Effect of 1.5% topical Diclofenac on Clinical Neuropathic Pain. Anesthesiology 123:191\u2013198. https:\/\/doi.org\/10.1097\/ALN.0000000000000693","journal-title":"Anesthesiology"},{"key":"6440_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4055\/CIOS20256","volume":"13","author":"JY Choi","year":"2021","unstructured":"Choi JY, Lee H, Il, Hong WH et al (2021) Corticosteroid injection for Morton\u2019s Interdigital Neuroma: a systematic review. Clin Orthop Surg 13:266. https:\/\/doi.org\/10.4055\/CIOS20256","journal-title":"Clin Orthop Surg"},{"key":"6440_CR29","doi-asserted-by":"publisher","unstructured":"van den Berg C, de Bree PN, Huygen FJPM, Tiemensma J (2022) Glucocorticoid treatment in patients with complex regional pain syndrome: A systematic review. Eur J Pain 26:2009. https:\/\/doi.org\/10.1002\/EJP.2025","DOI":"10.1002\/EJP.2025"},{"key":"6440_CR30","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1001\/JAMA.293.24.3043","volume":"293","author":"E Eisenberg","year":"2005","unstructured":"Eisenberg E, McNicol ED, Carr DB (2005) Efficacy and safety of opioid agonists in the treatment of Neuropathic Pain of Nonmalignant Origin: systematic review and Meta-analysis of Randomized controlled trials. JAMA 293:3043\u20133052. https:\/\/doi.org\/10.1001\/JAMA.293.24.3043","journal-title":"JAMA"},{"key":"6440_CR31","doi-asserted-by":"publisher","unstructured":"Mcnicol ED, Midbari A, Eisenberg E (2013) Opioids for neuropathic pain. Cochrane Database Syst Rev 2013(CD006146). https:\/\/doi.org\/10.1002\/14651858.CD006146.PUB2","DOI":"10.1002\/14651858.CD006146.PUB2"},{"key":"6440_CR32","unstructured":"TUE Physician Guidelines - Musculoskeletal conditions| World Anti Doping Agency (2025) https:\/\/www.wada-ama.org\/en\/resources\/therapeutic-use-exemption\/tue-physician-guidelines-musculoskeletal-conditions. Accessed 21 Jan"},{"key":"6440_CR33","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1136\/BJSPORTS-2017-097884","volume":"51","author":"B Hainline","year":"2017","unstructured":"Hainline B, Derman W, Vernec A et al (2017) International Olympic Committee consensus statement on pain management in elite athletes. Br J Sports Med 51:1253\u20131258. https:\/\/doi.org\/10.1136\/BJSPORTS-2017-097884","journal-title":"Br J Sports Med"},{"key":"6440_CR34","unstructured":"Reminder WADA\u2019 s 2024 Prohibited List comes into force on 1 January| World Anti Doping Agency. https:\/\/www.wada-ama.org\/en\/news\/reminder-wadas-2024-prohibited-list-comes-force-1-january. Accessed 21 Jan 2025"}],"container-title":["International Orthopaedics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-025-06440-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00264-025-06440-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00264-025-06440-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T02:41:44Z","timestamp":1743907304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00264-025-06440-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6440"],"URL":"https:\/\/doi.org\/10.1007\/s00264-025-06440-4","relation":{},"ISSN":["0341-2695","1432-5195"],"issn-type":[{"value":"0341-2695","type":"print"},{"value":"1432-5195","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}